Method for Reversal of Scleroderma-Associated Fibrotic Signatures Using Single-Cell Transcriptomic Analysis and Kinase Inhibition — USPTO Provisional Patent Specification

Abstract

This research paper explore the methodology and findings associated with Zenodo (CERN European Organization for Nuclear Research). The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).